Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Chaisson

Showing results (181-190 of 226) with videos related to

Pageof 23
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 15, 2017
Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trialR N Moro, T R Sterling, J Saukkonen, et al.
AIDS (London, England)|March 1, 1997
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infectionR E Chaisson, P Keiser, M Pierce, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 23, 2018
Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural MalawiK M Little, M Khundi, G L Barnes, et al.
AIDS Care|November 30, 2006
Establishing a workplace antiretroviral therapy programme in South AfricaS Charalambous, A D Grant, J H Day, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Cryptosporidiosis in patients with AIDS: correlates of disease and survivalY C Manabe, D P Clark, R D Moore, et al.
IJTLD Open|September 20, 2024
3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patientsA Kinikar, R Borse, B Randive, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 10, 2015
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosisR Dawson, K Narunsky, D Carman, et al.
JAMA|December 1, 1998
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapyW R Bishai, N M Graham, S Harrington, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 22, 2010
Controlled trial of active tuberculosis case finding in a Brazilian favelaA C Miller, J E Golub, S C Cavalcante, et al.
Annals of Internal Medicine|December 15, 1994
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamR E Chaisson, C A Benson, M P Dube, et al.
Pageof 23

Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 15, 2017
Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trialR N Moro, T R Sterling, J Saukkonen, et al.
AIDS (London, England)|March 1, 1997
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infectionR E Chaisson, P Keiser, M Pierce, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 23, 2018
Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural MalawiK M Little, M Khundi, G L Barnes, et al.
AIDS Care|November 30, 2006
Establishing a workplace antiretroviral therapy programme in South AfricaS Charalambous, A D Grant, J H Day, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 1998
Cryptosporidiosis in patients with AIDS: correlates of disease and survivalY C Manabe, D P Clark, R D Moore, et al.
IJTLD Open|September 20, 2024
3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patientsA Kinikar, R Borse, B Randive, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 10, 2015
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosisR Dawson, K Narunsky, D Carman, et al.
JAMA|December 1, 1998
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapyW R Bishai, N M Graham, S Harrington, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 22, 2010
Controlled trial of active tuberculosis case finding in a Brazilian favelaA C Miller, J E Golub, S C Cavalcante, et al.
Annals of Internal Medicine|December 15, 1994
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamR E Chaisson, C A Benson, M P Dube, et al.
Pageof 23